Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) …

Read More

Drop your comments

Click to Comment

Share this post with your friends on


COMMENTS (0)

Reply

All fields are required

Save my name for the next time I comment